112 related articles for article (PubMed ID: 31678538)
1. Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults.
Hattori N; Saito B; Matsui T; Nakata A; Sasaki Y; Shimada S; Murai S; Abe M; Baba Y; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Kabasawa N; Tsukamoto H; Uto Y; Yanagisawa K; Harada H; Nakamaki T
Biol Blood Marrow Transplant; 2020 Feb; 26(2):367-372. PubMed ID: 31678538
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord blood transplantation for adults using tacrolimus with two-day very-short-term methotrexate for graft-versus-host disease prophylaxis.
Saito B; Hattori N; Yamamoto K; Arai N; Kawaguchi Y; Fujiwara S; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Nakamaki T
Leuk Res; 2016 Aug; 47():161-5. PubMed ID: 27376545
[TBL] [Abstract][Full Text] [Related]
3. Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation.
Adachi Y; Ozeki K; Ukai S; Sagou K; Fukushima N; Kohno A
Int J Hematol; 2019 Apr; 109(4):440-450. PubMed ID: 30680665
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation.
Shigemura T; Sakashita K; Okura E; Morita D; Komori K; Kurata T; Hirabayashi K; Saito S; Tanaka M; Yanagisawa R; Nakazawa Y
Int J Hematol; 2020 May; 111(5):702-710. PubMed ID: 31953722
[TBL] [Abstract][Full Text] [Related]
5. Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura S; Wake A; Inamoto Y; Murata M; Sakai R; Yamaguchi T; Takahashi S; Uchida N; Onishi Y; Ohashi K; Ozawa Y; Kanamori H; Yamaguchi H; Fukuda T; Ichinohe T; Takanashi M; Atsuta Y; Teshima T
Bone Marrow Transplant; 2017 Mar; 52(3):423-430. PubMed ID: 27941766
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
Ho VT; Aldridge J; Kim HT; Cutler C; Koreth J; Armand P; Antin JH; Soiffer RJ; Alyea EP
Biol Blood Marrow Transplant; 2009 Jul; 15(7):844-50. PubMed ID: 19539216
[TBL] [Abstract][Full Text] [Related]
7. Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantation.
Yoshida S; Ohno Y; Nagafuji K; Yoshimoto G; Sugio T; Kamimura T; Ohta T; Takase K; Henzan H; Muta T; Iwasaki H; Ogawa R; Eto T; Akashi K; Miyamoto T
Ann Hematol; 2019 Nov; 98(11):2579-2591. PubMed ID: 31628517
[TBL] [Abstract][Full Text] [Related]
8. Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia.
Terakura S; Kuwatsuka Y; Sugita J; Takahashi S; Ozawa Y; Ozeki K; Yoshioka S; Nakamae H; Kawakita T; Sawa M; Morishige S; Najima Y; Katsuoka Y; Sakaida E; Kouzai Y; Kimura T; Ichinohe T; Fukuda T; Atsuta Y; Murata M; Teshima T
Int J Hematol; 2021 Jun; 113(6):840-850. PubMed ID: 33611725
[TBL] [Abstract][Full Text] [Related]
9. Minimum-Dose, Short-Term Methotrexate With Tacrolimus for Graft-vs-Host Disease Prophylaxis Following Unrelated Cord Blood Transplantation in Adults: A Retrospective Analysis at a Single Institution.
Iino M; Sato T; Sakamoto Y
Transplant Proc; 2021; 53(1):396-404. PubMed ID: 33308840
[TBL] [Abstract][Full Text] [Related]
10. Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
Mehta RS; Saliba RM; Rondon G; Al-Atrash G; Bashir Q; Hosing CM; Kebriaei P; Khouri I; Nieto Y; Oran B; Popat UR; Qazilbash MH; Ramdial J; Srour SA; Champlin RE; Rezvani K; Shpall EJ; Alousi AM
Transplant Cell Ther; 2022 Oct; 28(10):695.e1-695.e10. PubMed ID: 35902049
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
Iguchi A; Terashita Y; Sugiyama M; Ohshima J; Sato TZ; Cho Y; Kobayashi R; Ariga T
Pediatr Transplant; 2016 Feb; 20(1):114-9. PubMed ID: 26526424
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Chhabra S; Liu Y; Hemmer MT; Costa L; Pidala JA; Couriel DR; Alousi AM; Majhail NS; Stuart RK; Kim D; Ringden O; Urbano-Ispizua A; Saad A; Savani BN; Cooper B; Marks DI; Socie G; Schouten HC; Schoemans H; Abdel-Azim H; Yared J; Cahn JY; Wagner J; Antin JH; Verdonck LF; Lehmann L; Aljurf MD; MacMillan ML; Litzow MR; Solh MM; Qayed M; Hematti P; Kamble RT; Vij R; Hayashi RJ; Gale RP; Martino R; Seo S; Hashmi SK; Nishihori T; Teshima T; Gergis U; Inamoto Y; Spellman SR; Arora M; Hamilton BK
Biol Blood Marrow Transplant; 2019 Jan; 25(1):73-85. PubMed ID: 30153491
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the dosage of methotrexate combined with tacrolimus for graft-versus-host disease prophylaxis after cord blood transplantation.
Adachi M; Yokota D; Hirata H; Koyauchi K; Dohtan S; Oka S; Sakamoto N; Takaba M; Takemura T; Nagata Y; Naito K; Ono T
Int J Hematol; 2021 Aug; 114(2):252-262. PubMed ID: 34086252
[TBL] [Abstract][Full Text] [Related]
14. Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation.
Shiratori S; Ohigashi H; Takahashi S; Ara T; Goto H; Nakagawa M; Sugita J; Onozawa M; Kahata K; Endo T; Hashimoto D; Teshima T;
Ann Hematol; 2020 Mar; 99(3):591-598. PubMed ID: 32006152
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
Miyamoto T; Takashima S; Kato K; Takase K; Yoshimoto G; Yoshida S; Henzan H; Osaki K; Kamimura T; Iwasaki H; Eto T; Teshima T; Nagafuji K; Akashi K
Int J Hematol; 2017 Jan; 105(1):92-99. PubMed ID: 27686673
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
Huang B; Lin X; Zhang Z; Zhang Y; Zheng Z; Zhong C; He X; Chen M
Transplantation; 2020 Feb; 104(2):428-436. PubMed ID: 31283681
[TBL] [Abstract][Full Text] [Related]
17. A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.
Perkins J; Field T; Kim J; Kharfan-Dabaja MA; Fernandez H; Ayala E; Perez L; Xu M; Alsina M; Ochoa L; Sullivan D; Janssen W; Anasetti C
Biol Blood Marrow Transplant; 2010 Jul; 16(7):937-47. PubMed ID: 20102746
[TBL] [Abstract][Full Text] [Related]
18. GVHD prophylaxis by tacrolimus and mini-MTX in single-unit CBT: a single institute experience.
Fuji S; Tada Y; Nakata R; Nakata K; Koike M; Kida S; Tsutsumi K; Masaie H; Yoshida H; Ishikawa J
Int J Hematol; 2020 Feb; 111(2):278-283. PubMed ID: 31659626
[TBL] [Abstract][Full Text] [Related]
19. Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.
Freyer CW; Gier S; Moyer ME; Berryman N; Carulli A; Ganetsky A; Timlin C; Babushok DV; Frey NV; Gill SI; Hexner EO; Loren AW; Mangan JK; Martin ME; McCurdy S; Perl AE; Smith J; Luger SM; Stadtmauer EA; Porter DL
Transplant Cell Ther; 2021 May; 27(5):431.e1-431.e8. PubMed ID: 33965188
[TBL] [Abstract][Full Text] [Related]
20. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Narimatsu H; Terakura S; Matsuo K; Oba T; Uchida T; Iida H; Hamaguchi M; Watanabe M; Kohno A; Murata M; Sawa M; Miyamura K; Morishita Y
Bone Marrow Transplant; 2007 Jan; 39(1):31-9. PubMed ID: 17115066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
